{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:34:54Z","timestamp":1784252094611,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T00:00:00Z","timestamp":1524528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T00:00:00Z","timestamp":1524528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The emergence of &gt;300 serovars of<jats:italic>Leptospira<\/jats:italic>confounded the use of generalized bacterin, the whole cell lysate, as vaccines to control leptospirosis. Because of substantial genetic and geographic heterogeneity among circulating serovars, one vaccine strain per serovar cannot be efficacious against all the serovars. We have performed heterologous DNA prime-protein boost vaccination challenge studies in hamsters using<jats:italic>in vivo<\/jats:italic>expressed, leptospiral recombinase A (RecA) and flagellar hook associated protein (FliD). We prepared the monovalent recombinant protein, plasmid DNA, and DNA prime protein boost adjuvant vaccines. The whole cell bacterin served as a control. Our data show that (i) RecA and FliD have multiple immunogenic B and T-cell epitopes with highly conserved domains among most prevalent pathogenic<jats:italic>Leptospira<\/jats:italic>spp., (ii) humoral and cell mediated immune responses were induced remarkably, (iii) provides significant protection against homologous (Autumnalis strain N2) and cross-clade heterologous (Canicola strain PAI-1) challenge infection for the heterologous prime-protein boost (\u223c91\u2013100%) and, the DNA vaccine (\u223c75\u201383%). Recombinant protein vaccine shows only partial protection (\u223c58\u201366%), (iv) RecA prime-protein boost vaccine shows sterilizing immunity, with heterologous protection. This RecA\/FliD prime-protein boost strategy holds potential for vaccination against animal leptospirosis and for a better control of zoonotic transmission.<\/jats:p>","DOI":"10.1038\/s41598-018-24674-8","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T09:41:06Z","timestamp":1524044466000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Heterologous DNA prime-protein boost immunization with RecA and FliD offers cross-clade protection against leptospiral infection"],"prefix":"10.1038","volume":"8","author":[{"given":"Veerapandian","family":"Raja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sankaran","family":"Sobana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Solomon Akino","family":"Mercy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Cotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durlav Prasad","family":"Bora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalimuthusamy","family":"Natarajaseenivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,24]]},"reference":[{"key":"24674_CR1","doi-asserted-by":"publisher","first-page":"e0003898","DOI":"10.1371\/journal.pntd.0003898","volume":"9","author":"F Costa","year":"2015","unstructured":"Costa, F. et al. Global Morbidity and Mortality of Leptospirosis: A Systematic Review. PLoS Negl Trop Dis 9, e0003898, https:\/\/doi.org\/10.1371\/journal.pntd.0003898 (2015).","journal-title":"PLoS Negl Trop Dis"},{"key":"24674_CR2","first-page":"679","volume":"42","author":"K Natarajaseenivasan","year":"2011","unstructured":"Natarajaseenivasan, K. et al. Seroprevalence of Leptospira borgpetersenii serovar javanica infection among dairy cattle, rats and humans in the Cauvery river valley of southern India. Southeast Asian J Trop Med Public Health 42, 679\u2013686 (2011).","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"24674_CR3","unstructured":"WHO. Leptospirosis: an emerging public health problem. Wkly Epidemiol Rec\/Heal Sect Secr Leag Nations 45\u201352 (2011)."},{"key":"24674_CR4","doi-asserted-by":"publisher","first-page":"e18279","DOI":"10.1371\/journal.pone.0018279","volume":"6","author":"MG Goris","year":"2011","unstructured":"Goris, M. G. et al. Potent innate immune response to pathogenic leptospira in human whole blood. PLoS One 6, e18279, https:\/\/doi.org\/10.1371\/journal.pone.0018279 (2011).","journal-title":"PLoS One"},{"key":"24674_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/104063879100300209","volume":"3","author":"CA Bolin","year":"1991","unstructured":"Bolin, C. A., Cassells, J. A., Hill, H. T., Frantz, J. C. & Nielsen, J. N. Reproductive failure associated with Leptospira interrogans serovar bratislava infection of swine. J Vet Diagn Invest 3, 152\u2013154, https:\/\/doi.org\/10.1177\/104063879100300209 (1991).","journal-title":"J Vet Diagn Invest"},{"key":"24674_CR6","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.4161\/hv.7.11.17944","volume":"7","author":"OA Dellagostin","year":"2011","unstructured":"Dellagostin, O. A. et al. Recombinant vaccines against leptospirosis. Hum Vaccin 7, 1215\u20131224, https:\/\/doi.org\/10.4161\/hv.7.11.17944 (2011).","journal-title":"Hum Vaccin"},{"key":"24674_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/1040841X.2013.787387","volume":"41","author":"V Raja","year":"2015","unstructured":"Raja, V. & Natarajaseenivasan, K. Pathogenic, diagnostic and vaccine potential of leptospiral outer membrane proteins (OMPs). Crit Rev Microbiol 41, 1\u201317, https:\/\/doi.org\/10.3109\/1040841x.2013.787387 (2015).","journal-title":"Crit Rev Microbiol"},{"key":"24674_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fimmu.2017.00256","volume":"8","author":"AA Grassmann","year":"2017","unstructured":"Grassmann, A. A., Souza, J. D. & McBride, A. J. A Universal Vaccine against Leptospirosis: Are We Going in the Right Direction? Front Immunol 8, 256, https:\/\/doi.org\/10.3389\/fimmu.2017.00256 (2017).","journal-title":"Front Immunol"},{"key":"24674_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1099\/00207713-44-2-362","volume":"44","author":"JL Herrmann","year":"1994","unstructured":"Herrmann, J. L. et al. A new serovar in the Grippotyphosa serogroup comprising leptospiral isolates from different regions. Int J Syst Bacteriol 44, 362\u2013364, https:\/\/doi.org\/10.1099\/00207713-44-2-362 (1994).","journal-title":"Int J Syst Bacteriol"},{"key":"24674_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0065-3519(99)80015-9","volume":"41","author":"LA Babiuk","year":"1999","unstructured":"Babiuk, L. A., Lewis, J., van den Hurk, S. & Braun, R. DNA immunization: present and future. Adv Vet Med 41, 163\u2013179 (1999).","journal-title":"Adv Vet Med"},{"key":"24674_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.coi.2009.05.016","volume":"21","author":"S Lu","year":"2009","unstructured":"Lu, S. Heterologous prime-boost vaccination. Curr Opin Immunol 21, 346\u2013351, https:\/\/doi.org\/10.1016\/j.coi.2009.05.016 (2009).","journal-title":"Curr Opin Immunol"},{"key":"24674_CR12","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1590\/S0100-879X2009005000013","volume":"42","author":"CY Feng","year":"2009","unstructured":"Feng, C. Y. et al. Immune strategies using single-component LipL32 and multi-component recombinant LipL32-41-OmpL1 vaccines against leptospira. Braz J Med Biol Res 42, 796\u2013803 (2009).","journal-title":"Braz J Med Biol Res"},{"key":"24674_CR13","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/CVI.00034-13","volume":"20","author":"DD Hartwig","year":"2013","unstructured":"Hartwig, D. D. et al. A prime-boost strategy using the novel vaccine candidate, LemA, protects hamsters against leptospirosis. Clin Vaccine Immunol 20, 747\u2013752, https:\/\/doi.org\/10.1128\/cvi.00034-13 (2013).","journal-title":"Clin Vaccine Immunol"},{"key":"24674_CR14","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1128\/IAI.74.3.1745-1750.2006","volume":"74","author":"RU Palaniappan","year":"2006","unstructured":"Palaniappan, R. U. et al. Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect Immun 74, 1745\u20131750, https:\/\/doi.org\/10.1128\/iai.74.3.1745-1750.2006 (2006).","journal-title":"Infect Immun"},{"key":"24674_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1128\/CVI.00509-15","volume":"23","author":"V Raja","year":"2015","unstructured":"Raja, V. et al. In Vivo-Expressed Proteins of Virulent Leptospira interrogans Serovar Autumnalis N2 Elicit Strong IgM Responses of Value in Conclusive Diagnosis. Clin Vaccine Immunol 23, 65\u201372, https:\/\/doi.org\/10.1128\/cvi.00509-15 (2015).","journal-title":"Clin Vaccine Immunol"},{"key":"24674_CR16","first-page":"551","volume":"70","author":"K Natarajaseenivasan","year":"2000","unstructured":"Natarajaseenivasan, K. & Ratnam, S. Recent leptospira isolates from tamil nadu. Indian Journal of Animal Sciences 70, 551\u2013555 (2000).","journal-title":"Indian Journal of Animal Sciences"},{"key":"24674_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1590\/S1517-83822013005000029","volume":"44","author":"KM Forster","year":"2013","unstructured":"Forster, K. M. et al. Characterization of a virulent Leptospira interrogans strain isolated from an abandoned swimming pool. Braz J Microbiol 44, 165\u2013170 (2013).","journal-title":"Braz J Microbiol"},{"key":"24674_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jmr.893","volume":"21","author":"Y El-Manzalawy","year":"2008","unstructured":"El-Manzalawy, Y., Dobbs, D. & Honavar, V. Predicting linear B-cell epitopes using string kernels. J Mol Recognit 21, 243\u2013255, https:\/\/doi.org\/10.1002\/jmr.893 (2008).","journal-title":"J Mol Recognit"},{"key":"24674_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00251-011-0579-8","volume":"64","author":"E Karosiene","year":"2012","unstructured":"Karosiene, E., Lundegaard, C., Lund, O. & Nielsen, M. NetMHCcons: a consensus method for the major histocompatibility complex class I predictions. Immunogenetics 64, 177\u2013186, https:\/\/doi.org\/10.1007\/s00251-011-0579-8 (2012).","journal-title":"Immunogenetics"},{"key":"24674_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-10-296","volume":"10","author":"M Nielsen","year":"2009","unstructured":"Nielsen, M. & Lund, O. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics 10, 296, https:\/\/doi.org\/10.1186\/1471-2105-10-296 (2009).","journal-title":"BMC Bioinformatics"},{"key":"24674_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00251-011-0513-0","volume":"63","author":"J Greenbaum","year":"2011","unstructured":"Greenbaum, J. et al. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics 63, 325\u2013335, https:\/\/doi.org\/10.1007\/s00251-011-0513-0 (2011).","journal-title":"Immunogenetics"},{"key":"24674_CR22","doi-asserted-by":"publisher","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","volume":"110","author":"D Weiskopf","year":"2013","unstructured":"Weiskopf, D. et al. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells. Proc Natl Acad Sci USA 110, E2046\u20132053, https:\/\/doi.org\/10.1073\/pnas.1305227110 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"24674_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-8-361","volume":"8","author":"HH Bui","year":"2007","unstructured":"Bui, H. H., Sidney, J., Li, W., Fusseder, N. & Sette, A. Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinformatics 8, 361, https:\/\/doi.org\/10.1186\/1471-2105-8-361 (2007).","journal-title":"BMC Bioinformatics"},{"key":"24674_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova, I. A. & Flower, D. R. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics 8, 4, https:\/\/doi.org\/10.1186\/1471-2105-8-4 (2007).","journal-title":"BMC Bioinformatics"},{"key":"24674_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0022172400026450","volume":"84","author":"B Adler","year":"1980","unstructured":"Adler, B. & Faine, S. Immunogenicity of boiled compared with formalized leptospiral vaccines in rabbits, hamsters and humans. J Hyg (Lond) 84, 1\u201310 (1980).","journal-title":"J Hyg (Lond)"},{"key":"24674_CR26","first-page":"139","volume":"68","author":"K Natarajaseenivasan","year":"1997","unstructured":"Natarajaseenivasan, K. & Ratnam, S. Seroprevalence of leptospiral infection in an agriculture based village in Tamilnadu. Cheiron 68, 139\u2013140 (1997).","journal-title":"Cheiron"},{"key":"24674_CR27","doi-asserted-by":"publisher","first-page":"7048","DOI":"10.1128\/JVI.74.15.7048-7054.2000","volume":"74","author":"CH Kim","year":"2000","unstructured":"Kim, C. H. et al. DNA vaccines encoding viral glycoproteins induce nonspecific immunity and Mx protein synthesis in fish. J Virol 74, 7048\u20137054 (2000).","journal-title":"J Virol"},{"key":"24674_CR28","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1128\/IAI.00447-06","volume":"74","author":"F Vernel-Pauillac","year":"2006","unstructured":"Vernel-Pauillac, F. & Merien, F. Proinflammatory and immunomodulatory cytokine mRNA time course profiles in hamsters infected with a virulent variant of Leptospira interrogans. Infect Immun 74, 4172\u20134179, https:\/\/doi.org\/10.1128\/iai.00447-06 (2006).","journal-title":"Infect Immun"},{"key":"24674_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-2-13","volume":"2","author":"LD Smythe","year":"2002","unstructured":"Smythe, L. D. et al. A quantitative PCR (TaqMan) assay for pathogenic Leptospira spp. BMC Infect Dis 2, 13 (2002).","journal-title":"BMC Infect Dis"},{"key":"24674_CR30","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1016\/j.vaccine.2007.05.053","volume":"25","author":"EF Silva","year":"2007","unstructured":"Silva, E. F. et al. The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 25, 6277\u20136286, https:\/\/doi.org\/10.1016\/j.vaccine.2007.05.053 (2007).","journal-title":"Vaccine"},{"key":"24674_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1475-2859-6-39","volume":"6","author":"Z Wang","year":"2007","unstructured":"Wang, Z., Jin, L. & Wegrzyn, A. Leptospirosis vaccines. Microb Cell Fact 6, 39, https:\/\/doi.org\/10.1186\/1475-2859-6-39 (2007).","journal-title":"Microb Cell Fact"},{"key":"24674_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10389-014-0611-1","volume":"22","author":"S Prabhakaran","year":"2014","unstructured":"Prabhakaran, S., Shanmughapriya, S., Dhanapaul, S., James, A. & Natarajaseenivasan, K. Risk factors associated with rural and urban epidemics of leptospirosis in Tiruchirappalli District of Tamilnadu, India. J Public Health 22, 323\u2013333 (2014).","journal-title":"J Public Health"},{"key":"24674_CR33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.56093\/ijans.v82i7.21750","volume":"82","author":"C Lakshmipriya","year":"2012","unstructured":"Lakshmipriya, C., Anandhagiri, S. & Natarajaseenivasan, K. Diagnosis of canine leptospirosis by 16S rRNA nested PCR. Indian Journal of Animal Sciences 82, 37\u201340 (2012).","journal-title":"Indian Journal of Animal Sciences"},{"key":"24674_CR34","doi-asserted-by":"crossref","unstructured":"Natarajaseenivasan, K., Lakshmi Priya, C., Vanithamani, S., Shanmughapriya, S. & Anandhagiri, S. Humoral immune response of inactivated bivalent Leptospira vaccine among dogs in Tiruchirappalli, Tamilnadu, India. World J Vaccine, 85\u201390 (2012).","DOI":"10.4236\/wjv.2012.22011"},{"key":"24674_CR35","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2958.2010.07262.x","volume":"77","author":"DA Haake","year":"2010","unstructured":"Haake, D. A. & Matsunaga, J. Leptospira: a spirochaete with a hybrid outer membrane. Mol Microbiol 77, 805\u2013814 (2010).","journal-title":"Mol Microbiol"},{"key":"24674_CR36","first-page":"210","volume":"51","author":"N Koizumi","year":"2005","unstructured":"Koizumi, N. & Watanabe, H. Leptospirosis vaccines: past, present, and future. J Postgrad Med 51, 210\u2013214 (2005).","journal-title":"J Postgrad Med"},{"key":"24674_CR37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.vaccine.2007.10.029","volume":"26","author":"SM Faisal","year":"2008","unstructured":"Faisal, S. M. et al. Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters. Vaccine 26, 277\u2013287, https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.029 (2008).","journal-title":"Vaccine"},{"key":"24674_CR38","doi-asserted-by":"publisher","first-page":"e1422","DOI":"10.1371\/journal.pntd.0001422","volume":"5","author":"ML Coutinho","year":"2011","unstructured":"Coutinho, M. L. et al. A LigA three-domain region protects hamsters from lethal infection by Leptospira interrogans. PLoS Negl Trop Dis 5, e1422 (2011).","journal-title":"PLoS Negl Trop Dis"},{"key":"24674_CR39","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1128\/CVI.00601-12","volume":"20","author":"KM Forster","year":"2013","unstructured":"Forster, K. M. et al. A conserved region of leptospiral immunoglobulin-like A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis. Clin Vaccine Immunol 20, 725\u2013731, https:\/\/doi.org\/10.1128\/cvi.00601-12 (2013).","journal-title":"Clin Vaccine Immunol"},{"key":"24674_CR40","doi-asserted-by":"publisher","first-page":"e0004403","DOI":"10.1371\/journal.pntd.0004403","volume":"10","author":"DE Fouts","year":"2016","unstructured":"Fouts, D. E. et al. What Makes a Bacterial Species Pathogenic?:Comparative Genomic Analysis of the Genus Leptospira. PLoS Negl Trop Dis 10, e0004403, https:\/\/doi.org\/10.1371\/journal.pntd.0004403 (2016).","journal-title":"PLoS Negl Trop Dis"},{"key":"24674_CR41","doi-asserted-by":"publisher","first-page":"6831","DOI":"10.1128\/IAI.69.11.6831-6838.2001","volume":"69","author":"C Branger","year":"2001","unstructured":"Branger, C. et al. Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination. Infect Immun 69, 6831\u20136838, https:\/\/doi.org\/10.1128\/iai.69.11.6831-6838.2001 (2001).","journal-title":"Infect Immun"},{"key":"24674_CR42","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1128\/IAI.73.7.4062-4069.2005","volume":"73","author":"C Branger","year":"2005","unstructured":"Branger, C. et al. Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1. Infect Immun 73, 4062\u20134069, https:\/\/doi.org\/10.1128\/iai.73.7.4062-4069.2005 (2005).","journal-title":"Infect Immun"},{"key":"24674_CR43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/20477724.2016.1222054","volume":"110","author":"K Sivasankari","year":"2016","unstructured":"Sivasankari, K., Shanmughapriya, S. & Natarajaseenivasan, K. Leptospiral renal colonization status in asymptomatic rural population of Tiruchirapalli district, Tamilnadu, India. Pathog Glob Health 110, 209\u2013215, https:\/\/doi.org\/10.1080\/20477724.2016.1222054 (2016).","journal-title":"Pathog Glob Health"},{"key":"24674_CR44","doi-asserted-by":"publisher","first-page":"e0005441","DOI":"10.1371\/journal.pntd.0005441","volume":"11","author":"NL Conrad","year":"2017","unstructured":"Conrad, N. L. et al. LigB subunit vaccine confers sterile immunity against challenge in the hamster model of leptospirosis. PLoS Negl Trop Dis 11, e0005441, https:\/\/doi.org\/10.1371\/journal.pntd.0005441 (2017).","journal-title":"PLoS Negl Trop Dis"},{"key":"24674_CR45","doi-asserted-by":"publisher","first-page":"e1004828","DOI":"10.1371\/journal.ppat.1004828","volume":"11","author":"S Gupta","year":"2015","unstructured":"Gupta, S. & Garg, N. J. A Two-Component DNA-Prime\/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi. PLoS Pathog 11, e1004828, https:\/\/doi.org\/10.1371\/journal.ppat.1004828 (2015).","journal-title":"PLoS Pathog"},{"key":"24674_CR46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.vaccine.2007.10.052","volume":"26","author":"FK Seixas","year":"2007","unstructured":"Seixas, F. K. et al. Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine 26, 88\u201395, https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.052 (2007).","journal-title":"Vaccine"},{"key":"24674_CR47","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1590\/0074-02760150222","volume":"110","author":"KM Forster","year":"2015","unstructured":"Forster, K. M. et al. DNA prime-protein boost based vaccination with a conserved region of leptospiral immunoglobulin-like A and B proteins enhances protection against leptospirosis. Mem Inst Oswaldo Cruz 110, 989\u2013995, https:\/\/doi.org\/10.1590\/0074-02760150222 (2015).","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"24674_CR48","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.micinf.2005.03.010","volume":"7","author":"K Huygen","year":"2005","unstructured":"Huygen, K. Plasmid DNA vaccination. Microbes Infect 7, 932\u2013938, https:\/\/doi.org\/10.1016\/j.micinf.2005.03.010 (2005).","journal-title":"Microbes Infect"},{"key":"24674_CR49","doi-asserted-by":"publisher","first-page":"633","DOI":"10.4049\/jimmunol.175.2.633","volume":"175","author":"JJ Donnelly","year":"2005","unstructured":"Donnelly, J. J., Wahren, B. & Liu, M. A. DNA vaccines: progress and challenges. J Immunol 175, 633\u2013639 (2005).","journal-title":"J Immunol"},{"key":"24674_CR50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1053\/j.ajkd.2008.11.032","volume":"54","author":"J Scharpe","year":"2009","unstructured":"Scharpe, J. et al. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. Am J Kidney Dis 54, 77\u201385, https:\/\/doi.org\/10.1053\/j.ajkd.2008.11.032 (2009).","journal-title":"Am J Kidney Dis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24674-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24674-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24674-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T03:35:38Z","timestamp":1720236938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24674-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,24]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["24674"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-24674-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,24]]},"assertion":[{"value":"28 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6447"}}